Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Hypermarcas Total Assets 2010-2025 | HYPMY

Hypermarcas total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
Hypermarcas Annual Total Assets
(Millions of US $)
2024 $4,553
2023 $4,909
2022 $4,601
2021 $3,672
2020 $3,346
2019 $3,020
2018 $2,888
2017 $3,173
2016 $3,293
2015 $4,831
2014 $5,934
2013 $5,827
2012 $6,516
2011 $8,008
2010 $5,703
2009 $3,194
Hypermarcas Quarterly Total Assets
(Millions of US $)
2025-03-31 $4,153
2024-12-31 $4,553
2024-09-30 $4,665
2024-06-30 $4,861
2024-03-31 $5,103
2023-12-31 $4,909
2023-09-30 $4,971
2023-06-30 $4,810
2023-03-31 $4,335
2022-12-31 $4,601
2022-09-30 $4,302
2022-06-30 $4,250
2022-03-31 $3,899
2021-12-31 $3,672
2021-09-30 $3,838
2021-06-30 $3,503
2021-03-31 $3,288
2020-12-31 $3,346
2020-09-30 $3,177
2020-06-30 $2,917
2020-03-31 $2,734
2019-12-31 $3,020
2019-09-30 $2,736
2019-06-30 $2,686
2019-03-31 $2,742
2018-12-31 $2,888
2018-09-30 $2,603
2018-06-30 $2,751
2018-03-31 $2,985
2017-12-31 $3,173
2017-09-30 $3,140
2017-06-30 $3,267
2017-03-31 $3,386
2016-12-31 $3,293
2016-09-30 $3,842
2016-06-30 $3,720
2016-03-31 $3,422
2015-12-31 $4,831
2015-09-30 $4,238
2015-06-30 $5,032
2015-03-31 $4,642
2014-12-31 $5,934
2014-09-30 $6,003
2014-06-30 $5,892
2014-03-31 $5,444
2013-12-31 $5,827
2013-09-30 $5,825
2013-06-30 $6,225
2013-03-31 $6,344
2012-12-31 $6,516
2012-09-30 $6,380
2012-06-30 $6,780
2012-03-31 $7,393
2011-12-31 $8,008
2011-09-30 $8,385
2011-06-30 $8,608
2011-03-31 $7,833
2010-12-31 $5,703
2010-09-30 $5,112
2010-06-30 $4,570
2010-03-31 $3,578
2009-12-31 $3,194
2009-09-30 $2,336
2009-06-30 $1,757
2009-03-31 $1,563
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $3.178B $1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.529B 28.33
Zoetis (ZTS) United States $67.467B 25.17
Takeda Pharmaceutical (TAK) Japan $46.838B 9.32
Daiichi Sankyo, - (DSNKY) Japan $44.157B 22.63
BeOne Medicines - (ONC) Cayman Islands $30.596B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.886B 0.00
Summit Therapeutics (SMMT) United States $20.995B 0.00
Merck (MKKGY) Germany $16.698B 12.23
Shionogi (SGIOY) Japan $14.207B 14.23
United Therapeutics (UTHR) United States $13.449B 11.90
Neurocrine Biosciences (NBIX) United States $13.210B 45.25
Orion OYJ (ORINY) Finland $10.973B 29.68
IPSEN (IPSEY) France $10.239B 0.00
Stevanato Group S.p.A (STVN) Italy $7.732B 47.28
Corcept Therapeutics (CORT) United States $7.725B 62.80
Madrigal Pharmaceuticals (MDGL) United States $7.659B 0.00
Grifols, S.A (GRFS) Spain $6.937B 0.00
Ionis Pharmaceuticals (IONS) United States $6.807B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.310B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.987B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.589B 14.00
Catalyst Pharmaceuticals (CPRX) United States $2.583B 9.05
NewAmsterdam Pharma (NAMS) Netherlands $2.349B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.090B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.797B 0.00
Ocular Therapeutix (OCUL) United States $1.792B 0.00
ARS Pharmaceuticals (SPRY) United States $1.755B 0.00
Endo (NDOI) United States $1.602B 0.00
Evotec AG (EVO) Germany $1.499B 0.00
Guardian Pharmacy Services (GRDN) United States $1.315B 0.00
Harrow (HROW) United States $1.267B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.196B 23.92
Ardelyx (ARDX) United States $1.101B 0.00
ProKidney (PROK) United States $1.092B 0.00
Dyne Therapeutics (DYN) United States $1.061B 0.00
Enliven Therapeutics (ELVN) United States $1.053B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.030B 0.00
Akebia Therapeutics (AKBA) United States $1.024B 0.00
Collegium Pharmaceutical (COLL) United States $1.021B 5.51
Verve Therapeutics (VERV) United States $0.982B 0.00
Xeris Biopharma Holdings (XERS) United States $0.823B 0.00
KalVista Pharmaceuticals (KALV) United States $0.789B 0.00
Cronos Group (CRON) Canada $0.775B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.751B 0.00
Zevra Therapeutics (ZVRA) United States $0.674B 0.00
Xencor (XNCR) United States $0.628B 0.00
Relay Therapeutics (RLAY) United States $0.624B 0.00
USANA Health Sciences (USNA) United States $0.583B 12.68
Theravance Biopharma (TBPH) United States $0.583B 0.00
Elite Pharmaceuticals (ELTP) United States $0.568B 0.00
Organogenesis (ORGO) United States $0.566B 0.00
Oruka Therapeutics (ORKA) United States $0.554B 0.00
Bioventus (BVS) United States $0.545B 13.83
Siga Technologies (SIGA) United States $0.484B 10.12
Tourmaline Bio (TRML) United States $0.476B 0.00
Aquestive Therapeutics (AQST) United States $0.400B 0.00
Savara (SVRA) United States $0.399B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.345B 9.31
Altimmune (ALT) United States $0.339B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.332B 0.00
Aldeyra Therapeutics (ALDX) United States $0.309B 0.00
Heron Therapeutics (HRTX) United States $0.308B 0.00
AleAnna (ANNA) United States $0.305B 0.00
Nektar Therapeutics (NKTR) United States $0.300B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 25.78
Nanobiotix S.A (NBTX) France $0.246B 0.00
OmniAb (OABI) United States $0.242B 0.00
Esperion Therapeutics (ESPR) United States $0.222B 0.00
MediWound (MDWD) Israel $0.216B 0.00
Larimar Therapeutics (LRMR) United States $0.205B 0.00
4D Molecular Therapeutics (FDMT) United States $0.197B 0.00
China SXT Pharmaceuticals (SXTC) China $0.194B 0.00
Galectin Therapeutics (GALT) United States $0.180B 0.00
Profound Medical (PROF) Canada $0.173B 0.00
Aclaris Therapeutics (ACRS) United States $0.171B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Lyell Immunopharma (LYEL) United States $0.141B 0.00
Avita Medical (RCEL) United States $0.141B 0.00
Liminatus Pharma (LIMN) United States $0.140B 0.00
Lexeo Therapeutics (LXEO) United States $0.140B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Korro Bio (KRRO) United States $0.124B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.120B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Champions Oncology (CSBR) United States $0.108B 17.73
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Vivani Medical (VANI) United States $0.096B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Nutriband (NTRB) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.081B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Metagenomi (MGX) United States $0.079B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.078B 0.00
Rafael Holdings (RFL) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Jupiter Neurosciences (JUNS) United States $0.072B 0.00
Surrozen (SRZN) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Inotiv (NOTV) United States $0.064B 0.00
Wellgistics Health (WGRX) United States $0.061B 0.00
Klotho Neurosciences (KLTO) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.058B 43.11
Unicycive Therapeutics (UNCY) United States $0.058B 0.00
ElectroCore (ECOR) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.036B 0.00
Vivos Therapeutics (VVOS) United States $0.036B 0.00
Telomir Pharmaceuticals (TELO) United States $0.034B 0.00
FibroGen (FGEN) United States $0.030B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
DURECT (DRRX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Plus Therapeutics (PSTV) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 2.57
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
BioVie (BIVI) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.12
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00